Development of a mixed-effect pharmacokinetic model for vehicle modulated in vitro transdermal flux of topically applied penetrants.

Transient flux profiles from in vitro flow-through cell experiments exhibit different characteristics depending upon the properties of the penetrants and vehicle mixtures applied. To enable discrimination of the chemical properties contributing to these differences, a consistent mathematical model should first be developed. A mixed effects modeling framework was used so that models can be estimated with as few parameters as possible, while also quantifying variability and accounting for correlation in the data. The models account for diffusion and binding within the membrane as well as dynamics on the diffusion coefficient. The models explain key features of the data, such as: lag time, sharp peaks in flux, two terminal phases, and low flux profiles. The models with dynamic diffusivity fit the data better than those without-particularly the sharp peaks. The significance of changing diffusivity over time suggests that vehicle effects are transient and are more accurately estimated when dynamics are modeled.

[1]  J. W. Wiechers,et al.  The barrier function of the skin in relation to percutaneous absorption of drugs , 1989, Pharmaceutisch Weekblad.

[2]  William E. Schiesser,et al.  A Compendium of Partial Differential Equation Models: Method of Lines Analysis with Matlab , 2009 .

[3]  Roberts,et al.  Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. , 2000, Journal of pharmaceutical sciences.

[4]  A. Bunge,et al.  A New Method for Estimating Dermal Absorption from Chemical Exposure. 1. General Approach , 1993, Pharmaceutical Research.

[5]  R. Guy,et al.  Optimization of Topical Therapy: Partitioning of Drugs into Stratum Corneum , 1990, Pharmaceutical Research.

[6]  J. Riviere,et al.  Predicting skin permeability from complex chemical mixtures. , 2005, Toxicology and applied pharmacology.

[7]  G B Kasting,et al.  Kinetics of finite dose absorption through skin 1. Vanillylnonanamide. , 2001, Journal of pharmaceutical sciences.

[8]  J. Hadgraft,et al.  Effect of Vehicle Pretreatment on the Flux, Retention, and Diffusion of Topically Applied Penetrants in Vitro , 2003, Pharmaceutical Research.

[9]  E. Chatelain,et al.  Skin Penetration and Sun Protection Factor of Five UV Filters: Effect of the Vehicle , 2003, Skin Pharmacology and Physiology.

[10]  Samir Mitragotri,et al.  Mathematical models of skin permeability: an overview. , 2011, International journal of pharmaceutics.

[11]  Johannes M Nitsche,et al.  Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin. , 2011, Journal of pharmaceutical sciences.

[12]  Adrian C. Williams,et al.  Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement , 2004, Pharmaceutical Research.

[13]  R. Savic,et al.  Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.

[14]  K. Sugibayashi,et al.  Time-dependent percutaneous absorption enhancing effect of ethanol , 1995 .

[15]  Gerald B. Kasting,et al.  A Spreadsheet-Based Method for Estimating the Skin Disposition of Volatile Compounds: Application to N,N-Diethyl-m-Toluamide (DEET) , 2008, Journal of occupational and environmental hygiene.

[16]  H. F. Frasch,et al.  Modeling of Diffusion with Partitioning in Stratum Corneum Using a Finite Element Model , 2005, Annals of Biomedical Engineering.

[17]  R. Weiner,et al.  On mathematical modeling of dermal and transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[18]  J. Riviere,et al.  Prediction of dermal absorption from complex chemical mixtures: incorporation of vehicle effects and interactions into a QSPR framework , 2007, SAR and QSAR in environmental research.

[19]  Michael S Roberts,et al.  Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics. , 2009, Journal of pharmaceutical sciences.

[20]  J. Riviere,et al.  Predicting skin permeability from complex chemical mixtures: dependency of quantitative structure permeation relationships on biology of skin model used. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  Peter M. Pinsky,et al.  Finite Element Modeling of Coupled Diffusion with Partitioning in Transdermal Drug Delivery , 2005, Annals of Biomedical Engineering.

[22]  P. Williams,et al.  The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin. , 1996, Toxicology and Applied Pharmacology.

[23]  Philip S. Magee,et al.  Modelling In Vivo Human Skin Absorption , 1997 .

[24]  Y. Kalia,et al.  Passive skin penetration enhancement and its quantification in vitro. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[25]  G. W. Jepson,et al.  Predicting vehicle effects on the dermal absorption of halogenated methanes using physiologically based modeling. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  J E Riviere,et al.  Modelling the effect of mixture components on permeation through skin. , 2010, International journal of pharmaceutics.

[27]  J E Riviere,et al.  Percutaneous absorption of parathion in vitro in porcine skin: effects of dose, temperature, humidity, and perfusate composition on absorptive flux. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[28]  H Frederick Frasch,et al.  The transient dermal exposure: theory and experimental examples using skin and silicone membranes. , 2008, Journal of pharmaceutical sciences.

[29]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[30]  M. Abraham,et al.  Human skin permeation and partition: general linear free-energy relationship analyses. , 2004, Journal of pharmaceutical sciences.

[31]  Carol S. Woodward,et al.  Enabling New Flexibility in the SUNDIALS Suite of Nonlinear and Differential/Algebraic Equation Solvers , 2020, ACM Trans. Math. Softw..

[32]  A. Bunge,et al.  A New Method for Estimating Dermal Absorption from Chemical Exposure: 2. Effect of Molecular Weight and Octanol-Water Partitioning , 2004, Pharmaceutical Research.

[33]  Darach Golden,et al.  Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. , 2007, Journal of pharmaceutical sciences.

[34]  William E. Schiesser,et al.  A Compendium of Partial Differential Equation Models: Frontmatter , 2009 .

[35]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[36]  Yuri Dancik,et al.  Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure. , 2013, Advanced drug delivery reviews.